KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Equity Average (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Equity Average for 16 consecutive years, with -$99.0 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 86.98% to -$99.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$99.0 million through Dec 2025, up 86.98% year-over-year, with the annual reading at -$916.5 million for FY2025, 34.68% down from the prior year.
  • Equity Average hit -$99.0 million in Q4 2025 for Bausch Health Companies, down from $251.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $346.5 million in Q4 2022 to a low of -$760.5 million in Q4 2024.
  • Historically, Equity Average has averaged -$81.7 million across 5 years, with a median of -$86.0 million in 2021.
  • Biggest five-year swings in Equity Average: skyrocketed 510.06% in 2022 and later plummeted 1402.78% in 2024.
  • Year by year, Equity Average stood at -$84.5 million in 2021, then surged by 510.06% to $346.5 million in 2022, then tumbled by 145.74% to -$158.5 million in 2023, then tumbled by 379.81% to -$760.5 million in 2024, then skyrocketed by 86.98% to -$99.0 million in 2025.
  • Business Quant data shows Equity Average for BHC at -$99.0 million in Q4 2025, $251.5 million in Q3 2025, and -$46.5 million in Q2 2025.